European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Quality assurance in pathology in colorectal cancer screening and diagnosis

P. Quirke; M. Risio; R. Lambert; L. von Karsa; M. Vieth

doi:10.1055/s-0032-1309797

Endoscopy, Table of Contents

Endoscopy 2012; 44(S 03): SE116-SE130
DOI: 10.1055/s-0032-1309797

Guidelines

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Quality assurance in pathology in colorectal cancer screening and diagnosis

P. Quirke

¹Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom

,

M. Risio

²Pathology Department, Institute for Cancer Research and Treatment, Turin, Italy

,

R. Lambert

³Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France

,

L. von Karsa

⁴Quality Assurance Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France

,

M. Vieth

⁵Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany

› Author Affiliations

Abstract

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on quality assurance in pathology in colorectal cancer screening and diagnosis includes 23 graded recommendations. The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of the screening process, including multi-disciplinary diagnosis and management of the disease.

Keywords

mass screening - colorectal neoplasms - histopathology - classification - precursor lesions - multidisciplinary evidence-based guidelines - population-based programmes

Full Text

References

References
1 Atkin W, Valori R, Kuipers EJ et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Colonoscopic surveillance following adenoma removal. Endoscopy 2012; 44: SE151-SE163
2 Austoker J, Giordano L, Hewitson P et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Communication. Endoscopy 2012; 44: SE164-SE185
3 Beattie GC, McAdam TK, Elliott S et al. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma--a comparative study. Colorectal Dis 2003; 5: 558-562
4 Blumberg D, Paty PB, Guillem JG et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999; 42: 881-885
5 Branston LK, Greening S, Newcombe RG et al. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer 2002; 38: 764-772
6 Burt R, Jass J. Hyperplastic Polyposis. World Health Organisation classification of tumours: Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000: 135-136
7 Cooper HS, Deppisch LM, Gourley WK et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 1995; 108: 1657-1665
8 Cooper HS, Deppisch LM, Kahn EI et al. Pathology of the malignant colorectal polyp. Hum Pathol 1998; 29: 15-26
9 Council of the European Union. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union; 2003: 34-38
10 Coverlizza S, Risio M, Ferrari A et al. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential.. Cancer 1989; 64: 1937-1947
11 Cross SS, Feeley KM, Angel CA. The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Pathol 1998; 51: 481-482
12 DAP-TM-30. Leitfaden zur Interpretation der Anforderungen der DIN EN ISO/IEC 17020 : 2004 und technische Kriterien fuer deren Anwendung zur Akkreditierung in der Pathologie/Neuropathologie. 2007 http://www.dap.de/95doc/DAP-TM-30.pdf Accessed 11/2/2012
13 Deinlein P, Reulbach U, Stolte M et al. Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma. Pathologe 2003; 24: 387-393
14 Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131
15 EC Working Group on Breast Screening Pathology. Quality assurance guidelines for pathology. Open biopsy and resection specimens. In: Perry N, Broeders M, de Wolf C, et al. (eds.) European guidelines for quality assurance in breast cancer screening and diagnosis. 4th. edition Luxembourg: Office for Official Publications of the European Communities; 2006
16 Eon Y, Le Douy JY, Lamer B et al. Quality and completeness of histopathology reports of rectal cancer resections. Results of an audit in Brittany.. Gastroenterol Clin Biol 2006; 30: 235-240
17 Fenger C, Bak M, Kronborg O et al. Observer reproducibility in grading dysplasia in colorectal adenomas: comparison between two different grading systems. J Clin Pathol 1990; 43: 320-324
18 Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. [Internet] Lyon, France: International Agency for Research on Cancer; 2010 Available from: http://globocan.iarc.fr Accessed on 05/04/2012
19 Gondal G, Grotmol T, Hofstad B et al. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy 2005; 37: 1193-1197
20 Haggitt RC, Glotzbach RE, Soffer EE et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89: 328-336
21 Halloran S, Launoy G, Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Faecal Occult Blood Testing. Endoscopy 2012; 44: SE65-SE87
22 Hassan C, Zullo A, Risio M et al. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum 2005; 48: 1588-1596
23 Jass JR, Baker K, Zlobec I et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a “fusion” pathway to colorectal cancer. Histopathology 2006; 49: 121-131
24 Jass JR, O'Brien J, Riddell RH et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 2008; 129: 13-23
25 Jass JR, Williams CB, Bussey HJ et al. Juvenile polyposis--a precancerous condition. Histopathology 1988; 13: 619-630
26 Kikuchi R, Takano M, Takagi K et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38: 1286-1295
27 Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993; 25: 455-461
28 Kudo S, Lambert R, Allen JI et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008; 68: 3-47
29 Landsorp-Vogelaar I, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis: First edition. Introduction. Endoscopy 2012; 44: SE15-SE30
30 Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia.. Am J Surg Pathol 1990; 14: 524-537
31 Malila N, Senore C, Armaroli P. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Organisation. Endoscopy 2012; 44: SE31-SE48
32 Masaki T, Matsuoka H, Sugiyama M et al. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol 2006; 21: 1115-1121
33 Minozzi S, Armaroli P, Banzi R et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis – First edition. Appendix 1: Systematic evidence review. 2010 http://bookshop.europa.eu/en/european-guidelines-for-quality-assurance-in-colorectal-cancer-screening-and-diagnosis-pbND3210390/ Accessed 11/2/2012
34 Minozzi S, Armaroli P, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Principles of evidence assessment and methods for reaching recommendations. Endoscopy 2012; 44: SE9-SE14
35 Moss S, Ancelle-Park R, Brenner H. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Evaluation and interpretation of screening outcomes. Endoscopy 2012;
36 Muto T, Bussey HJ, Morson BC. Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum. J Clin Pathol 1973; 26: 25-31
37 Nascimbeni R, Burgart LJ, Nivatvongs S et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45: 200-206
38 NHS Bowel Cancer Screening Programme. Reporting lesions in the NHS Bowel Cancer Screening Programme – guidelines from the Bowel Cancer Screening Programme Pathology Group. 2007 http://www.cancerscreening.nhs.uk/bowel/publications/nhsbcsp01.pdf Accessed 11/2/2012
39 Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002; 45: 628-634
40 Oppong C, Robertson N, Sherwood A et al. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 2002; 84: 290
41 Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50: 151-162
42 Quirke P, Cuvelier C, Ensari A et al. Evidence-based medicine: the time has come to set standards for staging. J Pathol 2010; 221: 357-360
43 Quirke P, Risio M, Lambert R et al. Quality assurance in pathology in colorectal cancer screening and diagnosis-European recommendations. Virchows Arch 2011; 458: 1-9
44 Quirke P, Williams GT. Minimum Dataset for Colorectal Cancer Histopathology Reports. London: Royal college of Pathologists; 1998
45 Quirke P, Williams GT, Ectors N et al. The future of the TNM staging system in colorectal cancer: time for a debate?. Lancet Oncol 2007; 8: 651-657
46 Rigby K, Brown SR, Lakin G et al. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 1999; 81: 401-403
47 Risio M, Baccarini P, Casson P et al. Histopathologic diagnosis in colorectal cancer screening: guidelines. Pathologica 2006; 98: 171-174
48 Risio M, Bussolati G, Senore C et al. Virtual microscopy for histology quality assurance of screen-detected polyps. J Clin Pathol 2010; 63: 916-920
49 Rocken C, Manke H. Accreditation in pathology. Systematic presentation and documentation of activities in pathology. Pathologe 2010; 31: 268-278
50 Sakuragi M, Togashi K, Konishi F et al. Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum 2003; 46: 1626-1632
51 Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol 2001; 36: 445-456
52 Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
53 Schmiegel W, Reinacher-Schick A, Arnold D et al. Update S3-guideline “colorectal cancer” 2008. Z Gastroenterol 2008; 46: 799-840
54 Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc 1997; 46: 492-496
55 Segnan N, Patnick J, von Karsa L (eds.) European guidelines for quality assurance in colorectal cancer screening and diagnosis – First edition. Luxembourg: European Commission, Publications Office of the European Union; 2010
56 SIGN. Scottish Intercollegiate Guidelines Network – Guidelines for the management of colorectal cancer. 2003 http://www.sign.ac.uk/pdf/sign67.pdf Accessed 11/2/2012
57 Snover DC, Jass JR, Fenoglio-Preiser C et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005; 124: 380-391
58 Sobin LH, Gospodarowicz MK, Wittekind C (eds) TNM Classification of Malignant Tumours. 7th. edition Wiley-Blackwell; 2009
59 Sobin LH, Wittekind C (eds.) TNM Classification of malignant tumours. 6th. edition New Jersey: John Wiley & Sons; 2002
60 Sobin LH, Wittekind C (eds.) TNM classification of malignant tumours. 5th. edition New York: John Wiley & Sons, Inc; 1997
61 Soetikno RM, Kaltenbach T, Rouse RV et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008; 299: 1027-1035
62 Steele RJC, Pox C, Kuipers EJ et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Management of lesions detected in colorectal cancer screening. Endoscopy 2012; 44: SE140-SE150
63 Steele RJC, Rey J-F, Lambert R. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Professional requirements and training. Endoscopy 2012; 44: SE106-SE115
64 Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch 2003; 442: 99-106
65 Suzuki N, Price AB, Talbot IC et al. Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients. Scand J Gastroenterol 2006; 41: 812-819
66 The Paris Classification. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: 3-43
67 Tominaga K, Fujinuma S, Endo T et al. Efficacy of the revised Vienna Classification for diagnosing colorectal epithelial neoplasias. World J Gastroenterol 2009; 15: 2351-2356
68 Torlakovic EE, Gomez JD, Driman DK et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008; 32: 21-29
69 Ueno H, Mochizuki H, Hashiguchi Y et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127: 385-394
70 Valori R, Rey J-F, Atkin W et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Quality assurance in endoscopy in colorectal screening and diagnosis. Endoscopy 2012; 44: SE88-SE105
71 Vereniging integrale kankercentra. Colon cancer. Nation-wide guideline, Version: 2.0. 2008 http://www.oncoline.nl/richtlijn/doc/index.php?type=save&richtlijn_id=598 Accessed 11/2/2012
72 Vereniging integrale kankercentra. Rectal cancer. Nation-wide guideline, Version: 2.0. 2008 http://www.oncoline.nl/richtlijn/doc/index.php?type=save&richtlijn_id=615 Accessed 11/2/2012
73 Vieth M, Quirke P, Lambert R et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Annex – Annotations of colorectal lesions. Endoscopy 2012; 44: SE131-SE139
74 Volk EE, Goldblum JR, Petras RE et al. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995; 109: 1801-1807
75 von Karsa L, Anttila A, Ronco G et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on Cancer Screening - First Report. Luxembourg: European Commission; 2008 http://ec.europa.eu/health/archive/ph_determinants/genetics/documents/cancer_screening.pdf Accessed 11/2/2012
76 von Karsa L, Lignini TA, Patnick J et al. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol 2010; 24: 381-396
77 Wang HS, Liang WY, Lin TC et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 2005; 48: 1182-1192
78 Washington MK, Berlin J, Branton P et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009; 133: 1539-1551
79 Wei JT, Miller EA, Woosley JT et al. Quality of colon carcinoma pathology reporting: a process of care study. Cancer 2004; 100: 1262-1267
80 WHO. Histological Typing of Intestinal Tumours. In: Jass JR, Sobin LH, (eds.) World Health Organisation International Histological Classification of Tumours. 30. Berlin: Springer; 1989
81 WHO. Pathology and genetics of tumours in the digestive system. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, (eds.) World Health Organization International Histological Classification of Tumours. Lyon: IARC Press; 2000: 105-119
82 Williams GT, Quirke P, Shepherd NA. Dataset for colorectal cancer. 2007 2nd. edition http://www.rcpath.org/resources/pdf/G049-ColorectalDataset-Sep07.pdf Accessed 11/2/2012
83 Williams GT, Quirke P, Shepherd NA. Dataset for colorectal cancer - Appendix C: Proforma for colorectal cancer resections. 2007 2nd. edition http://www.rcpath.org/resources/worddocs/G049ColorectalDatasetAppendixC-Sep07.doc Accessed 11/2/2012
84 Williams GT, Quirke P, Shepherd NA. Dataset for colorectal cancer – Appendix D: Proforma for local excision specimens. 2007 2nd. edition http://www.rcpath.org/resources/worddocs/G049ColorectalDatasetAppendixD-Sep07.doc Accessed 11/2/2012
85 Wilson JM, Jungner YG. Principles and practice of mass screening for disease. World Health Organization; 1968 http://whqlibdoc.who.int/php/WHO_PHP_34.pdf Accessed 11/2/2012